<DOC>
	<DOCNO>NCT00694707</DOCNO>
	<brief_summary>This study evaluate safety , efficacy , tolerability RGH-188 relative placebo adult patient ( 18-60 year age ) acute exacerbation schizophrenia .</brief_summary>
	<brief_title>Safety Efficacy RGH-188 Acute Exacerbation Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Male female 18 60 year age meeting DSMIV criterion schizophrenia ( paranoid type , disorganize type , catatonic type undifferentiated type ) base SCID total PANSS score great equal 80 less equal 120 Patients schizophrenia diagnosis minimum 1 year . Patients exhibit abnormality Physical Examination , abnormal vital sign , ECG , clinical laboratory value . Patients experience first episode psychosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>